NCT03429244View on ClinicalTrials.gov

PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

68Ga-PSMA-11 PET-MRI

Patients will undergo injection of 68Ga-PSMA-11 at the time of pre-treatment MRI scan and followed until biopsy and/or surgical resection.

Trial Locations (4)

46032

Indiana University Health North Hospital, Carmel

46202

Indiana University Health Hospital, Indianapolis

Indiana University Health Methodist Hospital, Indianapolis

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03429244 - PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer | Biotech Hunter | Biotech Hunter